Universe Pharmaceuticals (UPC) Other Non-Current Assets: 2021-2024
- Universe Pharmaceuticals' Other Non-Current Assets fell 100.00% to -$96,326 in Q1 2024 from the same period last year, while for Mar 2024 it was -$96,326, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $35,864 for FY2023, which is 98.53% down from last year.
- Latest data reveals that Universe Pharmaceuticals reported Other Non-Current Assets of -$96,326 as of Q1 2024, which was down 368.59% from $35,864 recorded in Q3 2023.
- In the past 5 years, Universe Pharmaceuticals' Other Non-Current Assets ranged from a high of $2,439.5 billion in Q3 2021 and a low of -$96,326 during Q1 2024.
- Its 3-year average for Other Non-Current Assets is $975.8 billion, with a median of $2.4 million in 2022.
- Data for Universe Pharmaceuticals' Other Non-Current Assets shows a maximum YoY plummeted of 100.00% (in 2024) over the last 5 years.
- Over the past 4 years, Universe Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $2,439.5 billion in 2021, then tumbled by 100.00% to $2.4 million in 2022, then plummeted by 98.53% to $35,864 in 2023, then slumped by 100.00% to -$96,326 in 2024.
- Its Other Non-Current Assets was -$96,326 in Q1 2024, compared to $35,864 in Q3 2023 and $2,439.5 billion in Q1 2023.
